(98 days)
Not Found
No
The device description and performance studies focus on mechanical features for needle safety and fluid administration, with no mention of AI or ML.
No.
This device is designed to facilitate the administration/withdrawal of fluids and protect against needlestick injuries, not to treat a disease or condition itself.
No
The device is designed for the administration or withdrawal of fluids, and for protecting against needlestick injuries, not for diagnosing medical conditions.
No
The device description clearly outlines physical components like needles, cannulas, and inserters, indicating it is a hardware medical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the administration or withdrawal of fluids from implanted ports and to protect against needlestick injuries. This is a direct interaction with the patient's circulatory system via an implanted device, not the analysis of biological samples in vitro (outside the body).
- Device Description: The description details a mechanical device for accessing an implanted port and preventing needlestick injuries. It does not involve reagents, assays, or the analysis of biological specimens.
- Lack of IVD Characteristics: There is no mention of analyzing blood, urine, tissue, or any other biological sample. The device's function is purely mechanical and related to fluid management and safety during access to an implanted port.
Therefore, this device falls under the category of a medical device, but not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The GRIPPER® Micro needle is designed for the administration into or withdrawal of fluids from implanted ports.
The GRIPPER® Micro needle is indicated for the administration into or withdrawal of fluids from implanted ports. It is designed to help protect against accidental needlestick injuries.
Product codes (comma separated list FDA assigned to the subject device)
FPA
Device Description
The GRIPPER® Micro needle is comprised of the inserter and the infusion site with extension tubing and a standard luer fitting; there are versions either with or without needless access connector y-site. The inserter incorporates a sharp trocar needle and retractor arm. The infusion site incorporates a small septum and an attached blunt cannula. When fully assembled, the inserter and infusion site are combined with the trocar needle inserted through the septum and blunt cannula. After insertion of the cannula and trocar into the implanted port, the inserter retractor arm is activated removing the trocar needle from the cannula and infusion site septum leaving the blunt cannula in the implanted port. The trocar needle tip is captured in the inserter to prevent needle stick injury, and the inserter is discarded. Upon removal of the infusion site from the implanted port, the blunt cannula is designed to further prevent needle stick injury that may result from rebounding action during infusion site extraction.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Health care professionals
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Testing: assessment of the physical properties of the GRIPPER® Micro 1.25 inch needle and its ability to achieve its intended use. Testing performed based on FDA Guidance: Guidance for Industry and FDA Staff - Medical Devices with Sharps Injury Prevention Features, August 2005 included force to attach and detach connections, force to activate and deactivate the safety features, rate of fluid flow simulating extremes of pressure and strength of joints and bonds. The Bench testing of the device confirmed the suitability of the device for its intended use. Biocompatibility assessment was performed, and the device was found biocompatible based on similarity of materials to predicate devices.
Clinical Testing: Human clinical studies were deemed not necessary. A Simulated Use Study was conducted according to the FDA Guidance: Guidance for Industry and FDA Staff - Medical Devices with Sharps Injury Prevention Features, August 2005. Health care professionals (experienced in accessing and de-accessing implantable portals) participated. The purpose of the study was to simulate actual clinical use of the GRIPPER Micro Needle System 1.25 inch by health care professionals, in terms of installation, activation of sharps protection and deaccess of the infusion site. The sample size was based on statistical rationale in the FDA guidance. All 500 activations resulted in successful captures of the trocar tip in the capture zone.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
All 500 activations resulted in successful captures of the trocar tip in the capture zone.
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.5440 Intravascular administration set.
(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
0
Klollso.
心
TAB 6
AUG. 3 - 2010
510(k) Summary
GRIPPER® Micro 1.25 Inch Needle
Traditional 510(k) - GRIPPER Micro 1.25 Smiths Medical ASD, Inc.
Confidential
1
smiths medical
bringing technology to life
510(k) Number:____
Page 1 of 3
April 23, 2010 Updated June 28, 2010 Date Prepared
Submitter Information
| Submitter's Name: | Smiths Medical ASD, Inc. |
|---|---|
| Address: | 1265 Grey Fox Road |
| St. Paul, MN 55112 |
Establishment Registration: 2183502
| Contact Person: | Rachelle Parsons, RAC
Sr. Regulatory Affairs Specialist |
|-----------------|------------------------------------------------------------|
| Phone:
Fax: | (651) 628-7018
(651) 628-7457 |
Device Information
| Trade Name: | GRIPPER® Micro Blunt Cannula, Non-Coring Safety Needle; 1.25 inch |
|---|---|
| Common Name: | GRIPPER® Micro Needle |
| Classification Name: | Intravascular Administration Set |
| Product Code: | FPA |
| Regulation: | 21 CFR §880.5440 |
Predicate Device(s)
The predicate devices are the currently marketed GRIPPER Micro Needles. The reference 510(k) number for these devices:
| Device | 510(k) |
|---|---|
| GRIPPER® Micro Blunt Cannula, Non-Coring Safety Needle | K072059 |
2
smiths medical
bringing technology to life
Page 2 of 3
Device Description
The GRIPPER® Micro needle is comprised of the inserter and the infusion site with extension tubing and a standard luer fitting; there are versions either with or without needless access connector y-site. The inserter incorporates a sharp trocar needle and retractor arm. The infusion site incorporates a small septum and an attached blunt cannula. When fully assembled, the inserter and infusion site are combined with the trocar needle inserted through the septum and blunt cannula. After insertion of the cannula and trocar into the implanted port, the inserter retractor arm is activated removing the trocar needle from the cannula and infusion site septum leaving the blunt cannula in the implanted port. The trocar needle tip is captured in the inserter to prevent needle stick injury, and the inserter is discarded. Upon removal of the infusion site from the implanted port, the blunt cannula is designed to further prevent needle stick injury that may result from rebounding action during infusion site extraction.
Intended Use
The GRIPPER® Micro needle is designed for the administration into or withdrawal of fluids from implanted ports.
Indications for Use
The GRIPPER® Micro needle is indicated for the administration into or withdrawal of fluids from implanted ports. It is designed to help protect against accidental needlestick injuries.
Summary of Non-Clinical Testing
The non-clinical testing included assessment of the physical properties of the GRIPPER® Micro 1.25 inch needle and its ability to achieve its intended use. The GRIPPER Micro 1.25 inch products meet the same specifications as set for the predicate device. Testing performed based on FDA Guidance: Guidance for Industry and FDA Staff - Medical Devices with Sharps Iniurv Prevention Features. August 2005 included force to attach and detach connections, force to activate and deactivate the safety features, rate of fluid flow simulating extremes of pressure and strength of joints and bonds. The Bench testing of the device confirmed the suitability of the device for its intended use.
Biocompatibility assessment of the device was performed. The purpose of the biocompatibility assessment was to ensure that biocompatibility had been established for the device. The device is biocompatible based on the similarity of the materials of construction to the predicate devices commercially marketed by Smiths Medical ASD, Inc.
Traditional 510(k) -- GRIPPER Micro 1.25 Smiths Medical ASD, Inc.
Confidential
3
smiths medical
bringing technology to life
Page 3 of 3
Summary of Clinical Testing
Human clinical studies were deemed not necessary to evaluate the safety or effectiveness of the GRIPPER® Micro Needle. A Simulated Use Study was condicted according to the FDA Guidance: Guidance for Industry and FDA Staff - Medical Devices with Sharps Injury Prevention Features, August 2005. Health care professionals were selected to participate in the simulated use evaluation from a cross section of users or potential users of the device. These participants were experienced in accessing and de-accessing implantable portals.
The purpose of the study was to simulate actual clinical use of the GRIPPER Micro Needle System 1.25 inch by health care professionals, in terms of installation, activation of sharps protection and deaccess of the infusion site. The sample size was based on the statistical rationale noted in the FDA guidance. All 500 activations resulted in successful captures of the trocar tip in the capture zone.
Statement of Equivalence
The GRIPPER ® Micro 1.25 inch Needle is substantially equivalent to the currently marketed GRIPPER Micro Needles based on a comparison of the indications for use and the technological characteristics of the device.
Conclusion
The GRIPPER® Micro 1.25 inch Needle is substantially equivalent to the currently marketed GRIPPER Micro Needles based on the indications for use, technological characteristics, materials of construction and principles of operation of the device. Bench tests confirmed the suitability of the device for its intended use.
Traditional 510(k) - GRIPPER Micro 1.25 Smiths Medical ASD, Inc.
Confidential
4
Image /page/4/Picture/0 description: The image shows the seal for the Department of Health & Human Services - USA. The seal is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract symbol that resembles a stylized caduceus or a representation of human figures. There are also a series of dots on the left side of the seal.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Ms. Rachelle Parsons Senior Regulatory Affairs Specialist Smiths Medical ASD, Incorporated 1265 Grey Fox Road St. Paul, Minnesota 55112
AUG 3 - 2010
Re: K101180
Trade/Device Name: GRIPPER® Micro Blunt Cannula Non- Coring Safety Needle Regulation Number: 21 CFR 880.5440 Regulation Name: Intravascular Administration Set Regulatory Class: II Product Code: FPA Dated: July 2, 2010 Received: July 6, 2010
Dear Ms. Parsons:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
5
Page 2- Ms. Parsons
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820): and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please go to
http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours
Susan Munro
Anthony D. Watson, B.S., M.S., M.B.A. Director
Division of Anesthesiology. General Hospital. Infection Control and Dental Devices Office of Device Evaluation . Center for Devices and Radiological Health
Enclosure
6
K10/1180
SMITHS MEDICAL ASD, INC. 510(k) Premarket Notification
GRIPPER® Micro Blunt Cannula Non-Coring Safety Needle Indications for Use
AUG 3 - 2010
510(k) Number: K101180
Device Name: GRIPPER® Micro Blunt Cannula Non-Coring Safety Needle
Indications for Use:
This product is indicated for the administration into or withdrawal of fluids from implanted ports. It is designed to help protect against accidental needlestick injuries.
Prescription Use X (Per 21 CFR 801 . 109)
AND/OR
Over-The Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Ri C. C
(Division Sign-Off)
Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: K1 01180
Traditional 510(k) - GRIPPER Micro 1.25 Smiths Medical ASD, Inc.
Confidential